TriptoBIO
$300,000 / 2 years Awarded January 2023 |
TriptoBIOCopenhagen, Denmark
About
TriptoBIO is a biotechnology company applying cutting-edge synthetic biology to efficiently manufacture high-quality drug substances, including male contraceptives. Their approach paves the way for low costs of production and to the consumer. Our Grant
MCI is supporting TriptoBIO to increase the efficiency and production of a yeast platform that produces triptonide, a male contraceptive candidate molecule that has shown efficacy and initial safety in multiple animal studies. Ultimately, this work intends to facilitate drug production costs comparable to female oral contraceptives. |
Publications
Hansen, N. L., Kjaerulff, L., Heck, Q. K., Forman, V., Staerk, D., Møller, B. L., & Andersen-Ranberg, J. (2022). Tripterygium wilfordii cytochrome P450s catalyze the methyl shift and epoxidations in the biosynthesis of triptonide. Nature communications, 13(1), 5011. https://doi.org/10.1038/s41467-022-32667-5
Hansen, N. L., Kjaerulff, L., Heck, Q. K., Forman, V., Staerk, D., Møller, B. L., & Andersen-Ranberg, J. (2022). Tripterygium wilfordii cytochrome P450s catalyze the methyl shift and epoxidations in the biosynthesis of triptonide. Nature communications, 13(1), 5011. https://doi.org/10.1038/s41467-022-32667-5
TriptoBIO In the News:
Meet MCI's Grantees & Fellows!
Our grantees and fellows represent some of the finest minds in the male contraception research community from around the world.
At Male Contraceptive Initiative, we prioritize funding research that aligns with our mission of driving male contraception closer to clinical trials. We strategically allocate our resources to support a diverse range of projects, focusing on non-hormonal and reversible methods that have the potential to meet the needs of a broader population. Our goal is to catalyze progress in this field and bring innovative male birth control options to market.
Discover the innovative research being conducted by our grantees and fellows by clicking on the buttons below:
At Male Contraceptive Initiative, we prioritize funding research that aligns with our mission of driving male contraception closer to clinical trials. We strategically allocate our resources to support a diverse range of projects, focusing on non-hormonal and reversible methods that have the potential to meet the needs of a broader population. Our goal is to catalyze progress in this field and bring innovative male birth control options to market.
Discover the innovative research being conducted by our grantees and fellows by clicking on the buttons below:
